Aspects of the tumor microenvironment involved in immune resistance and drug resistance
K Khalaf, D Hana, JTT Chou, C Singh… - Frontiers in …, 2021 - frontiersin.org
The tumor microenvironment (TME) is a complex and ever-changing “rogue organ”
composed of its own blood supply, lymphatic and nervous systems, stroma, immune cells …
composed of its own blood supply, lymphatic and nervous systems, stroma, immune cells …
The Notch signaling pathway: a potential target for cancer immunotherapy
Dysregulation of the Notch signaling pathway, which is highly conserved across species,
can drive aberrant epigenetic modification, transcription, and translation. Defective gene …
can drive aberrant epigenetic modification, transcription, and translation. Defective gene …
Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis
H Duan, Q Zhang, J Liu, R Li, D Wang, W Peng… - Pharmacological …, 2021 - Elsevier
Atherosclerosis, a chronic multifactorial disease, is closely related to the development of
cardiovascular diseases and is one of the predominant causes of death worldwide. Normal …
cardiovascular diseases and is one of the predominant causes of death worldwide. Normal …
Drug resistance driven by cancer stem cells and their niche
M Prieto-Vila, R Takahashi, W Usuba… - International journal of …, 2017 - mdpi.com
Drug resistance represents one of the greatest challenges in cancer treatment. Cancer stem
cells (CSCs), a subset of cells within the tumor with the potential for self-renewal …
cells (CSCs), a subset of cells within the tumor with the potential for self-renewal …
The role of Notch, Hedgehog, and Wnt signaling pathways in the resistance of tumors to anticancer therapies
V Kumar, M Vashishta, L Kong, X Wu, JJ Lu… - Frontiers in cell and …, 2021 - frontiersin.org
Resistance to therapy is the major hurdle in the current cancer management. Cancer cells
often rewire their cellular process to alternate mechanisms to resist the deleterious effect …
often rewire their cellular process to alternate mechanisms to resist the deleterious effect …
Breast cancer stem cells, heterogeneity, targeting therapies and therapeutic implications
X Zeng, C Liu, J Yao, H Wan, G Wan, Y Li… - Pharmacological …, 2021 - Elsevier
Both hereditary and sporadic breast cancer are suggested to develop from a stem cell
subcomponent retaining most key stem cell properties but with dysregulation of self-renewal …
subcomponent retaining most key stem cell properties but with dysregulation of self-renewal …
Therapeutic modulation of Notch signalling—are we there yet?
ER Andersson, U Lendahl - Nature reviews Drug discovery, 2014 - nature.com
The Notch signalling pathway is evolutionarily conserved and is crucial for the development
and homeostasis of most tissues. Deregulated Notch signalling leads to various diseases …
and homeostasis of most tissues. Deregulated Notch signalling leads to various diseases …
STAT3, stem cells, cancer stem cells and p63
M Galoczova, P Coates, B Vojtesek - Cellular & molecular biology letters, 2018 - Springer
Abstract Signal Transducer and Activator of Transcription 3 (STAT3) is a transcription factor
with many important functions in the biology of normal and transformed cells. Its regulation is …
with many important functions in the biology of normal and transformed cells. Its regulation is …
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways
N Takebe, PJ Harris, RQ Warren, SP Ivy - Nature reviews Clinical …, 2011 - nature.com
Tumor relapse and metastasis remain major obstacles for improving overall cancer survival,
which may be due at least in part to the existence of cancer stem cells (CSCs). CSCs are …
which may be due at least in part to the existence of cancer stem cells (CSCs). CSCs are …